With this device’s U.S. commercial launch, Tandem aims to expand its durable insulin pump business and provide individuals living with diabetes unparalleled control and comfort in managing their ...

insulin pumps and continuous glucose monitoring (CGM) devices – is the first such controller that is flexible enough to be used with a range of devices, and not just those sold by Tandem ...

“So the pump can determine based on my blood sugar and carbs, how much insulin to take.” The goal of the multi-year research with UVa and funded by Tandem is to develop a fully automated ...

The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is ...

Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

Medscape Medical News, May 17, 2024 Alert Tandem Recall Urges Updating App Used With Insulin Pump The recall warns of a software glitch with the t:connect mobile app that can lead to battery ...

MARKHAM, Ontario, December 10, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, ...

Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...

Means and SDs for glycohemoglobin, blood glucose, insulin dosages, and body weight for CSII and comparison conditions were subjected to meta-analytic procedures. Data regarding pump complications ...